RNA Advisors supports life sciences and healthcare companies and investors with target identification and portfolio planning. Our team’s experience helps our clients align their internal performance goals against well-supported projections of future outcomes for purposes of making capital allocation decisions. These decisions arise in a range of situations, such as in-licensing assets, investing in or acquiring companies, building product pipelines, and identifying label expansion opportunities for existing biopharmaceutical and biotech therapies.
